Biomia develops nature-inspired small molecule therapeutics for CNS disorders using AI-driven discovery and yeast-based biomanufacturing.
Biomia develops nature-inspired small molecule therapeutics for CNS disorders using AI-driven discovery and yeast-based biomanufacturing.